Claude Denham

4.2k citations
10 papers · 3.0k · 2 hit papers · h-index 7

Impact in

    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Lung Cancer Treatments and Mutations
    • Medical Imaging and Pathology Studies
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 2%
    • Lung Cancer Research Studies

Papers in

    • Pleural and Pulmonary Diseases 3
    • Occupational and environmental lung diseases 3
    • Lung Cancer Treatments and Mutations 2
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
    • Peptidase Inhibition and Analysis 1
    • Bone health and treatments 1

Claude Denham

10 papers receiving 2.9k citations

Claude Denham's Hit Papers

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma 2003 · 2.3k citations
2.3k0+8+17Years since publication50010001.5k2.0k

Peers

Claude Denham
Comparison fields: 5 of 86
  • Pulmonary and Respiratory Medicine 2.6k
  • Oncology 985
  • Biotechnology 184
  • Radiology, Nuclear Medicine and Imaging 280
  • Cancer Research 127
Replace Clet Niyikiza with:
Clet Niyikiza United States
Henk H. Hartgrink Netherlands
Éveline Boucher France
C.-H. Köhne Germany
Héctor Soto Parrà Italy
Tohru Nakagoe Japan
Giuseppe Roberto D’Agostino Italy
Joaquina Baranda United States
Masayuki Itabashi Japan
Avishay Sella United States
Claude Denham relative to Clet Niyikiza United States Clet Niyikiza's profile →
Citations per field
00.5×1.5×
Clet Niyikiza · 1×
Citations per year

Countries citing papers authored by Claude Denham

Since Specialization
Citations

This map shows the geographic impact of Claude Denham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Denham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Denham more than expected).

Fields of papers citing papers by Claude Denham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Denham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Denham. The network helps show where Claude Denham may publish in the future.

Co-authors

The 25 scholars most cited alongside Claude Denham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claude Denham Line = papers co-authored together Claude Denham links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Hit paper breakdown →
20032291
2
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
Hit paper breakdown →
2000606
3 201457
4 199634
5 200320
6 202318
7 200313
8 19933
9 20173
10 20131

About Claude Denham

Claude Denham is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Rheumatology and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (3 papers), Occupational and environmental lung diseases (3 papers), Lung Cancer Treatments and Mutations (2 papers), Peptidase Inhibition and Analysis (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Bone health and treatments (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Oncology (985 citations), Biotechnology (184 citations), Radiology, Nuclear Medicine and Imaging (280 citations) and Cancer Research (127 citations). Claude Denham has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Clet Niyikiza, U. Gatzemeier, Michael Boyer, E. Kaukel, James T. Symanowski, James J. Rusthoven, Paolo Paoletti, Nicholas J. Vogelzang, Christian Manegold and Pierre Ruffiè. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Anti-Cancer Drugs, Journal of Oral and Maxillofacial Surgery and Baylor University Medical Center Proceedings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact